This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Arkansas. Active years: 2010-2014.
Company Filing History:
Years Active: 2010-2014
Title: S Michael Owens: Innovator in Hapten Compounds and Monoclonal Antibodies
Introduction
S Michael Owens is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of immunology through his innovative research and development of hapten compounds and monoclonal antibodies. With a total of 2 patents, his work has the potential to impact the medical community significantly.
Latest Patents
Owens' latest patents include "Hapten compounds and compositions and uses thereof" and "Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine-like compounds." The first patent relates to hapten compounds that comprise either (+)methamphetamine or (+)amphetamine conjugated to a linker. These hapten compounds are designed to elicit an immune response to one or more of (+)methamphetamine, (+)amphetamine, or (+)MDMA. The second patent focuses on monoclonal antibodies that recognize at least one compound from the group consisting of (+)methamphetamine, (+)amphetamine, and (+)3,4-methylenedioxymethamphetamine ((+)MDMA). Importantly, these monoclonal antibodies do not recognize the negative forms of these substances.
Career Highlights
Owens is affiliated with the University of Arkansas, where he conducts his research and development. His work has garnered attention for its innovative approach to addressing issues related to substance abuse and addiction.
Collaborations
Some of his notable coworkers include Melinda Gunnell and F Ivy Carroll, who contribute to the collaborative research environment at the University of Arkansas.
Conclusion
S Michael Owens is a distinguished inventor whose work in hapten compounds and monoclonal antibodies holds promise for advancing medical research and treatment options. His contributions to the field are noteworthy and reflect his commitment to innovation.